MMJ Recs

NOVEMBER 20, 2023

This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

MMJ Recs

JULY 9, 2024

In this article, we explore how medical marijuana for multiple sclerosis symptoms helps patients, with its diverse cannabinoid components, alleviate MS symptoms, and enhance the quality of life for patients. ” Other cannabinoids, like cannabinol (CBN) and cannabigerol (CBG), also contribute to the plant’s medicinal benefits.

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

Cannabis Law Report

SEPTEMBER 10, 2021

This exciting partnership between these innovative startups aims to advance patient access to psychedelic treatments in Europe, and improve the quality of the psychedelic medicines produced in Europe. We look forward to working closely with the Clerkenwell Health team to advance our psychedelic drug programs through clinical trials.”.

Research and Development 104

Research and Development Clinical Trials Therapy Environment 104

Cannabis Law Report

JULY 28, 2021

The Company and Its Subsidiary KGK Science Have Also Completed the Pre-Qualification Audits of Its Canadian Facilities to Enable Clinical Trials in an Arrangement with Aleafia Health. The audits will enable KGK to conduct clinical trials in the areas of psychedelics and nutraceuticals, among other substances of study.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

The Cannigma

APRIL 12, 2023

CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. While CBN is often marketed as “the sleep cannabinoid ,” the reality is more complicated. Sleep is not often the focus of clinical trials on cannabis; rather it is often a secondary outcome. Has CBN been proven to help with sleep?

Sleep 135

Sleep Data Tincture Research and Development 135

Project CBD

FEBRUARY 28, 2023

sativa do not naturally contain cannabinoids, but they can become contaminated with CBD from other plant parts during processing. 13 Although many review authors reported inconclusive findings due to low-quality studies, they noted that evidence from human clinical trials seems to support CBD’s positive effects on nociceptive pain (i.e.,

CBD 144

CBD Seed-To-Sale Food Access 144

CannaMD

APRIL 23, 2020

In December of 2019, the company announced outstanding results in a pre-clinical mouse model of Parkinson’s disease. More specifically, they reported successfully using a cannabinoid-rich formula to get Parkinson’s-affected mice “back to baseline.” FDA in order to enter human clinical trial as early as this year!

Clinical Trials 116

Clinical Trials Research and Development Marijuana Treatment 116

Cannabis Law Report

JANUARY 14, 2022

Right-to-try aims to allow patients who have been diagnosed with life-threatening diseases or conditions who have tried all approved treatment options and who are unable to participate in a clinical trial to access certain unapproved treatments. Right-to-try permits those patients to have access to investigational drugs.

Treatment 52

Treatment Access Clinical Trials Patients 52

Cannabis Law Report

SEPTEMBER 8, 2021

Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).

Access 97

Access Research and Development Medicine THC 97

Veriheal

JUNE 30, 2023

For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial. The 13 individuals were chosen because of their reported improvements in negative drinking behavior following the clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Project CBD

NOVEMBER 11, 2023

Cannabinoid receptors are distributed throughout the body and brain, and I think that also accounts for some of the varied effects of cannabis and the possibility that it can treat many different conditions. states there are dispensaries where most people have access to cannabis drugs. Which cannabinoids do you standardize for?

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

Veriheal

JUNE 29, 2021

In order to legally access other therapies including nature-based options such as psilocybin , you must gain access under a Right to Try law which requires you to have a terminal condition. The FDA refers to this program as the expanded access program on their website. A Push by Patients. Patients Are Not In This Alone.

Therapy 64

Therapy DEA Patients Clinical Trials 64

Cannabis Law Report

AUGUST 14, 2021

Cann Group CEO Peter Crock said of the products: “Satipharm CBD capsules were one of the first medicinal cannabis products available to approved patients in Australia (under the Special Access Scheme) and have been successfully used in a variety of medical conditions since 2017.

CBD 105

CBD Clinical Trials Programs Medicine 105

The Cannigma

MAY 6, 2021

Along with delta-9-THC, delta-8 is one of the few cannabinoids considered to be intoxicating. (El The cannabis plant can produce a great number of active compounds — those unique to cannabis are called cannabinoids. Interestingly, along with delta-9-THC, delta-8 is one of the few cannabinoids considered to be intoxicating.

THC 145

THC Cannabinoids Concentrates Hemp 145

The Cannigma

FEBRUARY 2, 2021

Patients can also access CBD products without a prescription through local pharmacies. Our data confirm that PD patients have a high interest in treatment with medicinal cannabis but lacked knowledge about how to take it and especially the differences between the two main cannabinoids, THC and CBD,” said Buhmann.

Patients 89

Patients Clinical Trials Research and Development Treatment 89

Veriheal

MAY 3, 2022

a necessary question to address as medical marijuana becomes more accessible. Clinical Trial Sample Size. The trial was conducted with just 186 participants, which is far too small of a sample size to provide findings generalizable to the larger population.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Veriheal

APRIL 11, 2022

We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. We could potentially develop north of 11,000 drugs that are cannabinoid-based. This means that U.S.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

Veriheal

JULY 7, 2023

Plants hit with HLVd show issues like yellow leaves, abnormal branching, stunted development, and nearly 50% loss in cannabinoid production. In order to gain access to psychedelics, Australians firsts need to see a psychiatrist. Canada, and Israel are all conducting clinical trials on psychedelic treatments.

Legalization 97

Legalization Clinical Trials Research and Development History 97

Veriheal

MAY 26, 2022

Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. RoC also works to increase patients’ access to medical cannabis by helping U.S.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Veriheal

JANUARY 28, 2022

Poleg noted that “clinical trials testing cannabis treatments for autism usually involve strains containing very large amounts of CBD–due to this substance’s anti-inflammatory properties, and because it does not produce a sense of euphoria.”.

Oil 104

Oil THC Research and Development Treatment 104

Veriheal

OCTOBER 13, 2020

Ethan Russo theorized that IBS may present itself in an individual as a result of a deficiency in the body’s’ own cannabinoid chemicals, which are located in the endocannabinoid system (the ECS). Luckily, Dronabinol can be organically accessed in its botanical form, THC, directly from the plant. . Cannabis for GI Pathologies .

Digestion 124

Digestion Treatment Conditions Research and Development 124

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. However, because cannabinoids reduce seizures through numerous mechanisms of actions, possible drug interactions are still unclear. References Staff, T.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

The two active cannabinoids in marijuana are cannabidiol (CBD) and tetrahydrocannabinol (THC), the latter of which causes psychoactive effects while the former does not. This system naturally produces cannabinoids in the bloodstream, but chronic stress, anxiety, and other stimuli can stifle the production of natural endocannabinoids.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

TheAnswerPage

JANUARY 11, 2022

and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ In addition, if clinicians are not well informed about the health effects of cannabinoid-based products, clinicians will not be able to optimally treat their patients. million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

SEPTEMBER 22, 2021

Oxford Cannabinoid Technologies Holdings plc. . Access to Canopy Growth’s cannabinoid library including 335 derivatives and 14 patent families. Accelerated timelines to clinical trials and expansion of drug development pipeline. Exclusive licensing agreement with leading global cannabis company (“Canopy Growth”).

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Cannabinoids 52

Cannabis Law Report

NOVEMBER 22, 2019

. “As MMJ International Holdings continues to advance to its clinical trials, a specialty pharmaceutical solutions company will be supporting MMJ with the FDA, DEA required development API and specialized liquid encapsulation solutions,” said Elio Mariani, PhD, EVP of Research & Development.

DEA 51

DEA Clinical Trials THC Research and Development 51

The Cannigma

AUGUST 14, 2022

There is certainly some evidence that cannabis may be helpful with increasing focus, in the right dose with the right terpenes and cannabinoids. The short answer is maybe – it depends on several factors, including the cannabinoids and terpenes in your weed, as well as how much you consume. It starts with the right cannabinoids.

Terpenes 122

Terpenes Strains THC Oil 122

MedicalJane

JUNE 29, 2018

Food and Drug Administration (FDA) had approved only three cannabinoid-based medicines. percent of tetrahydrocannabinol (THC), the cannabinoid responsible for producing “high” psychoactive effects when consumed. Clinical trials show that Epidiolex significantly reduces seizure frequency. Prior to this week, the U.S.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

MMJ Recs

JULY 11, 2024

Medical marijuana refers to the use of cannabis and cannabinoids for medical purposes, such as using cannabis for insomnia relief, to alleviate symptoms, or to treat conditions under medical supervision. It consists of cannabinoid receptors, endocannabinoids produced by the body, and enzymes that regulate their synthesis and degradation.

Sleep 111

Sleep Treatment Research and Development Therapy 111

The Cannigma

JULY 1, 2022

Because of this variability in the plant, and because of a lack of standard methods–like chemical analyses of cannabinoids or terpenes–has led to inconsistent scientific results. This is because these types of studies control the most variables to ensure that the results that come out of the trial are as reliable as possible.

Research and Development 112

Research and Development Data THC Clinical Trials 112

Canna Care Docs

DECEMBER 11, 2018

Ultimately, beyond increased access, a big reason that seniors are turning to cannabis is that it helps with a range of health issues. Accessed December 5 2018. “Cannabis And Pain: A Clinical Review” Cannabis And Cannabinoid Research 2 (1): 96-104. . Accessed December 5 2018. Marijuana As Medicine.

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52

Safety Cannabinoids Events Data 52

Puff Puff Post

JANUARY 1, 2020

Cannabinoids even alleviate certain types of pain that opiates don’t always treat well. As a result, medical usage now grows substantially now that doctors and hospitals have access to legal cannabis. Furthermore, cannabinoids treat these symptoms as the doctors either do chemotherapy or prescribe antivirals for the HIV.

Treatment 49

Treatment Clinical Trials Research and Development Cannabinoids 49

Cannabis Law Report

SEPTEMBER 14, 2021

A lack of consumer trust, transparency and scientific rigor has hampered the CBD and cannabinoid industry from reaching its growth potential for far too long”. About Radicle Science. Radicle Science is a transformative healthtech B-corp offering the first ever path to natural product validation at scale.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

NOVEMBER 16, 2019

Current barriers to patient access to medicinal cannabis in Australia. On 14 November 2019, the Senate referred an inquiry into the current barriers to patient access to medicinal cannabis in Australia to the Senate Community Affairs References Committee for inquiry and report by 12 February 2020. Accessibility.

Clinical Trials 58

Clinical Trials Access Medicine Patients 58

The Joint Blog

JUNE 2, 2020

The study, titled Pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial , was first published by NORML. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo.

Chronic Pain 58

Chronic Pain Clinical Trials Marijuana Safety 58

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122